Suzanne Kincaid

COO

In her role as COO, Suzanne provides oversight and guidance for Aperio’s clinical trial execution and overall company operations.

Suzanne has over 25 years of clinical research experience, with 20 years in oncology. She has conducted clinical trials from every aspect, from a study coordinator to a global project manager. She was the Study Delivery Program Leader of AstraZeneca’s Oncology Phase I Team for the US and Director of Operations at Sarah Cannon’s Phase I Drug Development Unit. Suzanne is actively involved in her local chapter of the Association of Clinical Research Professionals (ACRP). She has served two terms as president and is in her 2nd term as treasurer. In 2020, Suzanne was honored as a PharmaVoice 100 most inspiring people in life sciences and became a Fellow of ACRP.

When she isn’t writing SOPs or mentoring her team, Suzanne enjoys listening to music (she was a DJ in her prior life!), spending time with her family and getting rid of her stress with Zumba classes.